WallStreetZenWallStreetZen

NASDAQ: ABOS
Acumen Pharmaceuticals Inc Stock Ownership - Who owns Acumen Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Acumen Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Derek M. MeisnerChief Legal Officer Corp Sec2024-01-198,933$3.48
$31.05kSell
Daniel Joseph OconnellPresident and CEO2024-01-1915,200$3.47
$52.76kSell
Matt ZugaCFO Chief Business Officer2024-01-184,242$3.71
$15.72kSell
Eric SiemersChief Medical Officer2024-01-183,124$3.71
$11.60kSell
Russell BartonChief Operating Officer2024-01-182,833$3.73
$10.56kSell
Jeffrey L. IvesDirector2023-08-172,800$1.19
$3.33kBuy
Jeffrey L. IvesDirector2023-08-172,800$6.66
$18.65kSell
Jeffrey L. IvesDirector2023-08-1739,149$6.48
$253.69kSell
Jeffrey L. IvesDirector2023-08-1739,149$0.72
$28.19kBuy
Ra Capital Management LPDirector2023-07-215,161,290$7.75
$40.00MBuy

1 of 1

ABOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABOS insiders and whales buy or sell their stock.

ABOS Shareholders

What type of owners hold Acumen Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP24.85%14,932,063$47.19MInstitution
Robert D. Hardie6.42%3,859,141$12.19MInsider
Sands Capital Ventures Discovery Fund Iii LP5.69%3,417,075$10.80MInsider
Sands Capital Ventures LLC5.69%3,417,075$10.80MInstitution
Franklin Resources Inc5.59%3,358,809$10.61MInstitution
Rock Springs Capital Management LP3.83%2,300,059$7.27MInstitution
Laurion Capital Management LP3.15%1,895,023$5.99MInstitution
Vanguard Group Inc3.06%1,839,552$5.81MInstitution
Knollwood Investment Advisory LLC2.71%1,628,510$5.15MInstitution
Millennium Management LLC2.49%1,495,284$4.73MInstitution

1 of 3

ABOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABOS63.98%16.58%Net Buying
INMB12.71%40.66%Net BuyingNet Buying
IPSC27.27%59.23%Net SellingNet Selling
VERU40.81%28.47%
ELEV53.13%24.22%Net SellingNet Selling
View Top Biotech Stocks

Acumen Pharmaceuticals Stock Ownership FAQ

Who owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals (NASDAQ: ABOS) is owned by 63.98% institutional shareholders, 16.58% Acumen Pharmaceuticals insiders, and 19.44% retail investors. Robert D. Hardie is the largest individual Acumen Pharmaceuticals shareholder, owning 3.86M shares representing 6.42% of the company. Robert D. Hardie's Acumen Pharmaceuticals shares are currently valued at $12.27M.

If you're new to stock investing, here's how to buy Acumen Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.